Home/Filings/4/0000891293-16-000135
4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-16-000135

CIK 0000891293operating

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:47 PM ET

Size

4.7 KB

Accession

0000891293-16-000135

Insider Transaction Report

Form 4
Period: 2016-03-21
Plunkett Matthew
EVP, Corporate Development
Transactions
  • Tax Payment

    Common Stock

    2016-03-21$0.55/sh63,874$35,016526,210 total
Footnotes (1)
  • [F1]Represents shares withheld by CTIC to satisfy minimum tax withholding obligations on the vesting of restricted stock.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:47 PM ET
Size
4.7 KB